Cancer drugs entering the market!

Already in the next year in the UK will begin widespread use of abiraterone - the most powerful drugs against prostate cancer of all, ever created. It reduces or stabilizes the tumor, which gave already metastasized. Experts call it a revolution in cancer medicine.

Abiraterone   first hit the headlines two years ago when they were published startling results of clinical trials of this agent. In 80% (!) Of cases it shrink tumors in patients in the final stages of cancer where malignant cells began to grow in other body organs.

This medicine, inter alia, greatly facilitates the symptom of pain in patients. Doctors call it the most significant breakthroughs in the world of oncology over the past 60 years. Further testing abiraterone wider uncovered before scientists effectiveness. The following year the British doctors can prescribe the drug to patients with advanced cases   Prostate Cancer .

What is the mechanism of action of the drug is based? Created in the laboratories of the British scientists, community-funded Cancer Research UK,   abiraterone blocking testosterone in the body, including the one that produced the most tumors. And testosterone is the main "fuel" cancer.

Currently used for oncology patients fourth stage Prostate Cancer   docetaxel, but it is able to extend the life of these patients by an average of two to three months, which of course is not exactly impressive result. Abiraterone reduces or stabilizes tumors at least twice as long. Unfortunately, he did not become a universal means of saving the lives of patients with an aggressive form Prostate Cancer , But the drug can significantly extend their life and improve its quality.

Industry News

Go back to the main page